What is Danaher Corporation (DHR)?

Danaher Corporation (DHR) is a stock in the Healthcare sector, Medical - Diagnostics & Research industry. View full analysis on Stocks360.

What is the current price of DHR?

The current price of DHR is $236.83. Prices are updated in real time on Stocks360.

What is DHR's price-to-earnings (PE) ratio?

DHR's trailing twelve-month PE ratio is 38.70, based on current price and earnings per share data available on Stocks360.

What is DHR's market capitalization?

DHR's market capitalization is $166,488,187,169.00, placing it in the large-cap tier.

Does DHR pay a dividend?

Yes. DHR has a trailing twelve-month dividend yield of 0.01%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Danaher Corporation (DHR)

Stock analysis · NYSE · Healthcare · Medical - Diagnostics & Research

$236.83

Market Cap

$166.49B

PE (TTM)

38.70

EPS (TTM)

N/A

Dividend Yield

0.64%

Beta

0.80

Day Range

$229.55 – $237.91

52-wk Range

$160.93 – $242.80

Avg Volume

N/A

Volume

1.24M

Danaher Corporation (DHR) is a publicly traded company in the Healthcare sector. Latest price: $236.83. Market cap $166.49B. Trailing PE 38.70. Dividend yield 0.64%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-28 · $216.90 2026-10-28 · $236.98 (+9.26%)

Earnings

Most Recent

Oct 21, 2026

EPS $2.11 vs est. $1.92

Beat by $0.19

Next Earnings

Jan 27, 2027

EPS estimate $2.48

Proprietary Signals

Signal snapshot temporarily unavailable.

About Danaher Corporation

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedica…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	38.70×
P/S (TTM)	6.50×
P/B	3.11×
PEG	1.52×
P/FCF (TTM)	29.07×
EV / EBITDA	26.43×
EV / Sales	7.31×
Earnings Yield	2.60%
Free Cash Flow Yield	3.44%
Dividend Yield	0.64%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$187.29B
Revenue (TTM)	$25.61B
Net Income (TTM)	$4.33B
Free Cash Flow (TTM)	$5.86B
Net Debt	$20.80B
Working Capital	$5.74B
Gross Margin	58.59%
Operating Margin	20.38%
Net Margin	16.91%
Return on Equity	8.18%
Return on Invested Capital	5.43%